OPER vs. SBIO
OPER (ClearShares Ultra-Short Maturity ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - OPER is a Ultrashort Bond fund tracking the ICE BofA U.S. Broad Market Index, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 5 years, OPER returned 3.65%/yr vs 2.68%/yr for SBIO. At a correlation of -0.01, they often move in opposite directions. OPER charges 0.20%/yr vs 0.50%/yr for SBIO.
Performance
OPER vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OPER achieves a 1.55% return, which is significantly higher than SBIO's -0.39% return.
OPER
- 1D
- 0.01%
- 1M
- 0.34%
- YTD
- 1.55%
- 6M
- 1.88%
- 1Y
- 4.07%
- 3Y*
- 4.80%
- 5Y*
- 3.65%
- 10Y*
- —
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
OPER vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
OPER ClearShares Ultra-Short Maturity ETF | 1.55% | 4.37% | 5.34% | 5.09% | 1.76% | 0.37% | 0.65% | 2.15% | 0.90% |
SBIO ALPS Medical Breakthroughs ETF | -0.39% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -24.85% |
Correlation
The correlation between OPER and SBIO is -0.14, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.02 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2018 | -0.01 |
The correlation between OPER and SBIO shifts across timeframes, from -0.14 (1 year) to -0.01 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OPER vs. SBIO — Risk / Return Rank
OPER
SBIO
OPER vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ClearShares Ultra-Short Maturity ETF (OPER) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OPER | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +13.21 | ||
| Sortino ratioReturn per unit of downside risk | +40.80 | ||
| Omega ratioGain probability vs. loss probability | 13.38 | 1.36 | +12.02 |
| Calmar ratioReturn relative to maximum drawdown | 61.29 | 5.19 | +56.09 |
| Martin ratioReturn relative to average drawdown | 519.55 | 15.57 | +503.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OPER | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 15.45 | 2.24 | +13.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 11.47 | 0.08 | +11.39 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.24 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 2.28 | 0.21 | +2.07 |
Drawdowns
OPER vs. SBIO - Drawdown Comparison
The maximum OPER drawdown since its inception was -2.33%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for OPER and SBIO.
Loading charts...
Drawdown Indicators
| OPER | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -2.33% | -63.06% | +60.73% |
Max Drawdown (1Y)Largest decline over 1 year | -0.07% | -12.66% | +12.59% |
Max Drawdown (3Y)Largest decline over 3 years | -0.11% | -42.44% | +42.33% |
Max Drawdown (5Y)Largest decline over 5 years | -0.13% | -53.10% | +52.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.06% | — |
Current DrawdownCurrent decline from peak | 0.00% | -16.79% | +16.79% |
Average DrawdownAverage peak-to-trough decline | -0.16% | -28.45% | +28.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.01% | 4.22% | -4.21% |
Volatility
OPER vs. SBIO - Volatility Comparison
The current volatility for ClearShares Ultra-Short Maturity ETF (OPER) is 0.10%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.48%. This indicates that OPER experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OPER | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.10% | 9.48% | -9.38% |
Volatility (6M)Calculated over the trailing 6-month period | 0.20% | 22.70% | -22.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.26% | 29.42% | -29.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.32% | 33.56% | -33.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1.23% | 33.17% | -31.94% |
OPER vs. SBIO - Expense Ratio Comparison
OPER has a 0.20% expense ratio, which is lower than SBIO's 0.50% expense ratio.
Dividends
OPER vs. SBIO - Dividend Comparison
OPER's dividend yield for the trailing twelve months is around 4.09%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
OPER ClearShares Ultra-Short Maturity ETF | 4.09% | 4.32% | 5.21% | 5.03% | 1.71% | 0.36% | 0.64% | 2.08% | 0.89% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
OPER and SBIO have a correlation of -0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.48%) compared to OPER (0.10%). In terms of maximum drawdown, OPER dropped -2.33% vs SBIO's -63.06%.
On 5-year performance, OPER leads with 3.65% vs 2.68% for SBIO. On fees, OPER is cheaper at 0.20% per year. On volatility, OPER has been the lower-risk option at 0.10%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, OPER has performed better with a 3.65% return vs 2.68%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
OPER is cheaper with a 0.20% expense ratio, compared with 0.50% for SBIO.
OPER has the higher dividend yield at 4.09%, compared with 0.00% for SBIO.
OPER is categorized as Ultrashort Bond, while SBIO is Health & Biotech Equities. OPER tracks ICE BofA U.S. Broad Market Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: ClearShares and SS&C. Their fees differ too: 0.20% for OPER and 0.50% for SBIO.
OPER currently has the higher Sharpe Ratio (15.45 vs 2.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OPER and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer